Articles

Find an Article

Filter articles

Applied Filters

Showing 751 to 760 of 932 results

Criminal proceedings and customs searches

Germany01-06-2011Jens Künzel

Every two years, the world’s largest trade fair for sanitary goods takes place in Frankfurt am Main, Germany.

Simplified destruction proceedings in Turkey

Turkey01-06-2011Isik Ozdogan and Ezgi Baklaci

The New Customs Regulation, which came into effect in October 2009, provides a new mechanism for intellectual property right holders, known as ‘simplified destruction’.

Patents in Ukraine

Ukraine01-06-2011Oleksandr Mamunya

Swiftly developing technology has always been an integral part of a growing economy. As one of the main engines of progress, innovation deserves to be legally protected.

The NDA: a valuable IP tool

US01-06-2011Paul J. Sutton

One of the most commonly used contracts covering intellectual property is the nondisclosure agreement.

Considerations for filing and prosecuting gene patents in Mexico

Mexico01-05-2011BiotechnologyFernando Rincón

On the basis of scientific breakthroughs in the past 30 years in the field of biotechnology, the number of patents has significantly increased, particularly in relation to genetic materials. Fernando Rincón looks at the Mexican situation.

Building operative partnerships with law enforcement

01-05-2011Vaughn Volpi

There is a perfect storm brewing in the healthcare industry. Over the past few years, there has been an unprecedented rise in the trade of illicit healthcare products in the secondary market.

Practice points in Israel patent prosecution: selection patents and treatment of earlier-filed patent applications

Israel01-05-2011Moshe Tritel

Israel patent practice is distinct from US and European practice in a number of respects. Moshe Tritel describes a number of such areas with important practical ramifications for applicants seeking to maximise their patent protection in Israel.

Clinical trials in BioPharma

US01-05-2011BiosimilarsEric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

Clinical trials and stratified medicine—maximising patent exclusivity

01-05-2011Richard Korn and Stephanie Pilkington

The traditional business model for a new drug relies on a substantial period of market exclusivity to recoup extensive research and development costs.

Traditional medicine patents lead to enhanced drug discovery from natural products

01-05-2011John Zabilski

Natural products have been used to relieve a variety of diseases and conditions for millennia.

Showing 751 to 760 of 932 results

WIPR